國立虎尾科技大學 |

登入

回首頁

Introduction to Biologic and Biosimi...

SpringerLink (Online service)

Introduction to Biologic and Biosimilar Product Development and Analysis

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Introduction to Biologic and Biosimilar Product Development and Analysis/ by Karen M. Nagel.
作者:	Nagel, Karen M.
面頁冊數:	XI, 109 p. 4 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmaceutical technology. -
電子資源:	https://doi.org/10.1007/978-3-319-98428-5
ISBN:	9783319984285

Introduction to Biologic and Biosimilar Product Development and Analysis
Nagel, Karen M.

Introduction to Biologic and Biosimilar Product Development and Analysis[electronic resource] /by Karen M. Nagel. - 1st ed. 2018. - XI, 109 p. 4 illus. in color.online resource. - AAPS Introductions in the Pharmaceutical Sciences,2522-834X. - AAPS Introductions in the Pharmaceutical Sciences,.

Recombinant DNA Technology -- Therapeutic Proteins -- Therapeutic Antibodies -- Analysis and Regulation of Biologics including Biosimilars.

The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.

ISBN: 9783319984285

Standard No.: 10.1007/978-3-319-98428-5doiSubjects--Topical Terms:

557391
Pharmaceutical technology.

LC Class. No.: RS380

Dewey Class. No.: 615.19

Introduction to Biologic and Biosimilar Product Development and Analysis
LDR:02038nam a22004215i 4500 001 991774
003 DE-He213
005 20200704065339.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319984285 $9 978-3-319-98428-5
024 7 $a 10.1007/978-3-319-98428-5 $2 doi
035 $a 978-3-319-98428-5
050 4 $a RS380
050 4 $a RS190-210
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 615.19 $2 23
100 1 $a Nagel, Karen M. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1209090
245 1 0 $a Introduction to Biologic and Biosimilar Product Development and Analysis $h [electronic resource] / $c by Karen M. Nagel.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a XI, 109 p. 4 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a AAPS Introductions in the Pharmaceutical Sciences, $x 2522-834X
505 0 $a Recombinant DNA Technology -- Therapeutic Proteins -- Therapeutic Antibodies -- Analysis and Regulation of Biologics including Biosimilars.
520 $a The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Pharmacy. $3 582411
650 1 4 $a Pharmaceutical Sciences/Technology. $3 768561
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319984278
776 0 8 $i Printed edition: $z 9783319984292
776 0 8 $i Printed edition: $z 9783030074920
830 0 $a AAPS Introductions in the Pharmaceutical Sciences, $x 2522-834X $3 1280580
856 4 0 $u https://doi.org/10.1007/978-3-319-98428-5
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得

Export

取書館別